← Leaderboards
Robert B Parker
University Of Tennessee Health Sci Ctr
$289,806
Attributed
$515,598
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $299.6K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$515,598 · 4
By mechanism
R15$299,584 · 1
R03$152,000 · 1
M01$64,014 · 2
Top collaborators
- Steven Casey Laizure2 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Russell W. Chesney$1,525,307
- Steven Casey Laizure$516,667
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralIn VivoEthanolMetabolismProdrugsPharmaceutical PreparationsDrug MetabolismEstersIntestinesLiverPharmacotherapyCarboxylesteraseSafetyToxic EffectAlcohol EffectDrug KineticsEffectivenessEnzymesAffectHydrolysisDoseCarboxylic Ester HydrolasesCarboxylesterase 1Animal Model
Grant awards (4)
The Inhibition and Transesterification of Dimethyl Fumarate by Ethanol$152,000
R03 · FY2020 · NS
Inhibition of Carboxylesterase Metabolism by Ethanol$299,584
R15 · FY2011 · GM · contact PI
EFFECT OF PAROXETINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF METOPROT$59,660
M01 · FY2006 · RR · contact PI
EFFECT OF PAROXETINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF METOPROT$4,354
M01 · FY2005 · RR